PulmCCM

PulmCCM

Share this post

PulmCCM
PulmCCM
NIV (BiPAP) for preoxygenation before intubation prevented hypoxemia and cardiac arrest (PREOXI trial)
Copy link
Facebook
Email
Notes
More

NIV (BiPAP) for preoxygenation before intubation prevented hypoxemia and cardiac arrest (PREOXI trial)

Compared to nonrebreather oxygen masks in the control group

PulmCCM's avatar
PulmCCM
Jun 16, 2024
∙ Paid
8

Share this post

PulmCCM
PulmCCM
NIV (BiPAP) for preoxygenation before intubation prevented hypoxemia and cardiac arrest (PREOXI trial)
Copy link
Facebook
Email
Notes
More
1
Share

A large randomized controlled trial found significant reductions in hypoxemia and cardiac arrest among critically ill patients undergoing rapid sequence intubation who received noninvasive ventilation during the preoxygenation and apneic phases of RSI.

The PREOXI trial enrolled 1,301 adults at seven emergency departments (27% of the intubations) and 17 …

Keep reading with a 7-day free trial

Subscribe to PulmCCM to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 PulmCCM LLC
Publisher Terms
Substack
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More